Follow CGSP on Social Media

Listen to the CGSP Podcast

COVID Wave Drives Chinese Consumers to Indian Generics

TRANSLATION: Thousands of dollars for Indian-made generic COVID medications sold out? Be careful!

As the BF7 Omicron variant pushes China’s public health care system to its limits, the country is running out of antiviral medications like Pfizer’s Paxlovid.

These shortages seem to be driving people to the black market, with consumers competing to order generic versions of the drug, many from India, that haven’t been approved in China.

Lead the Conversation on China

Subscribe Today to Get Full Access to The China-Global South Project

Check Out Everything You'll Get With Your Subscription

The China-Global South Daily Brief delivered to your inbox at 6AM Washington time

Full access to exclusive news and analysis from editors based in the Global South

Transcripts of CGSP’s twice-weekly podcasts

Students and teachers with a valid .edu email address are eligible for a 50% discount off monthly or yearly subscriptions. Email us to receive a discount code.

What is The China-Global South Project?


The China-Global South Project is passionately independent, non-partisan and does not advocate for any country, company or culture.


A carefully curated selection of the day’s most important China-Global South stories. Updated 24 hours a day by human editors. No bots, no algorithms.


Diverse, often unconventional insights from scholars, analysts, journalists and a variety of stakeholders in the China-Global South discourse.


A unique professional network of China-Africa scholars, analysts, journalists and other practioners from around the world.